Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-25-006746
Filing Date
2025-05-07
Accepted
2025-05-07 16:16:44
Documents
101
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q pahc-20250331x10q.htm   iXBRL 10-Q 2667255
2 EX-31.1 pahc-20250331xex31d1.htm EX-31.1 8055
3 EX-31.2 pahc-20250331xex31d2.htm EX-31.2 8025
4 EX-32.1 pahc-20250331xex32d1.htm EX-32.1 3778
5 EX-32.2 pahc-20250331xex32d2.htm EX-32.2 4048
  Complete submission text file 0001558370-25-006746.txt   11003689

Data Files

Seq Description Document Type Size
6 EX-101.SCH pahc-20250331.xsd EX-101.SCH 68628
7 EX-101.CAL pahc-20250331_cal.xml EX-101.CAL 93909
8 EX-101.DEF pahc-20250331_def.xml EX-101.DEF 359464
9 EX-101.LAB pahc-20250331_lab.xml EX-101.LAB 507099
10 EX-101.PRE pahc-20250331_pre.xml EX-101.PRE 549979
104 EXTRACTED XBRL INSTANCE DOCUMENT pahc-20250331x10q_htm.xml XML 2088564
Mailing Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666
Business Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666 201-329-7300
PHIBRO ANIMAL HEALTH CORP (Filer) CIK: 0001069899 (see all company filings)

EIN.: 131840497 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-36410 | Film No.: 25921638
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)